US Patent

US9216982 — Certain chemical entities, compositions and methods

Method of Use · Assigned to Intellikine LLC · Expires 2029-01-05 · 3y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent describes chemical entities that modulate PI3 kinase activity and methods of using them for treating diseases and conditions associated with PI3 kinase activity.

USPTO Abstract

Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2413 — Copiktra
U-2413 — Copiktra

Patent Metadata

Patent number
US9216982
Jurisdiction
US
Classification
Method of Use
Expires
2029-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Intellikine LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.